|
PEDIATRICS Vol. 116 No. 1 July 2005, pp. 270-273 (doi:10.1542/peds.2005-0875)
CLINICAL REPORT |
Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
Diabetic retinopathy (DR) is the leading cause of blindness in young adults in the United States. Early identification and treatment of DR can decrease the risk of vision loss in affected patients. This clinical report reviews the risk factors for the development of DR and screening guidance for pediatric patients with type 1 diabetes mellitus.
Key Words: type 1 diabetes mellitus diabetic retinopathy ophthalmic screening
Abbreviations: DR, diabetic retinopathy DCCT, Diabetes Control and Complications Trial
Statement of reaffirmation:
-
AAP Publications Retired and Reaffirmed
Pediatrics 2009 123: 1421-1422.[Extract] [Full Text] [PDF]
The following policy statement has been revised:
- Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
- Sections on Endocrinology and Ophthalmology
Pediatrics 1998 101: 313-314.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
![]() |
D. W. Cooke and L. Plotnick Type 1 Diabetes Mellitus in Pediatrics Pediatr. Rev., November 1, 2008; 29(11): 374 - 385. [Full Text] [PDF] |
||||
![]() |
E. Stefansson Diabetic Retinopathy Screening Pediatrics, February 1, 2006; 117(2): 586 - 586. [Full Text] [PDF] |
||||



